Aging-US: Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells
09-08-2021Aging-US published a Special Collection on Eye Disease which included "Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells" which reported that uveal melanoma (UM) is the most common primary intraocular tumour in adults.
Most accurate prognostic factor of UM is classification by gene expression profiling. These authors recently showed a strong prognostic role of the expression levels of histone variant macroH2A1 in UM patients. Mitochondrial function was assayed through qPCR and HPLC analyses. Correlation between mitochondrial gene expression and cancer aggressiveness was studied using a bioinformatics approach.
Correlation between mitochondrial gene expression and cancer aggressiveness was studied using a bioinformatics approach
Dr. Giovanni Li Volti and Dr. Manlio Vinciguerra said, "Uveal melanoma (UM) is the most common primary intraocular tumour in adults."
Metastasis is a frequent occurrence in uveal and cutaneous melanomas with a 5 years survival of 15%. By far the most common site of UM metastasis is the liver, reported in 87% of cases.
Epigenetic mechanisms controlling gene expression have long been known to have a role in cancer development. In UM these include DNA methylation at CpG islands leading to decrease expression of p16/INK4a tumour suppressor protein.
Figure 7. COX4|1 mRNA expression levels correlate with the surviving rate in UM metastatic patients. Correlation analysis of COX4|1 with surviving rate in (A) 88 metastatic (M-UM) and 102 (B) non-metastatic (not-M-UM) UM patients. Data are expressed as z-score intensity expression levels and presented as vertical scatter dot plots. Correlations were determined using Pearson’s ρ correlation. P values <0.05 were considered to be statistically significant (*p<0.05; **p<0.005;***p<0.0005; ****p<0.00005).
The Volti/Vinciguerra Research Team concluded in their Aging-US Research Output, "we suggest that strategies aiming at decreasing the expression of histone variant macroH2A1 [32], might effectively hamper the aggressiveness of UM cells, by inhibiting their mitochondrial phosphorylation. This could be a novel promising therapeutic strategy against UM [51]."
Full Text - https://www.aging-us.com/article/103241/text
Correspondence to: Giovanni Li Volti email: livolti@unict.it and Manlio Vinciguerra email: manlio.vinciguerra@fnusa.cz
Keywords: macroH2A1, histones, uveal melanoma, metabolism, epigenetics
About Aging-US:
Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.
Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
Please visit our website at www.Aging-US.com and connect with us:
- X
- YouTube
- Spotify, Apple, SoundCloud, and available wherever you listen to podcasts
For media inquiries, please contact media@impactjournals.com.